Efficacy of the Bispecific Anti-BAFF/IL-21 Antibody CZ105 Bis2 in Models of Systemic Lupus Erythematosus.
- DOI
- 10.1002/art.70310
- Published
- 2026 Aug 27
- Container
- Arthritis & rheumatology (Hoboken, N.J.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/art.70310,
title = {Efficacy of the Bispecific Anti-BAFF/IL-21 Antibody CZ105 Bis2 in Models of Systemic Lupus Erythematosus.},
author = {Feng X and Long D and Yin H and Li L and Wang Z and Zhao J and Fan X and Wu W and Wu H and Lu Q},
year = {2026},
journal = {Arthritis \& rheumatology (Hoboken, N.J.)},
doi = {10.1002/art.70310},
url = {https://doi.org/10.1002/art.70310}
}RIS
TY - JOUR TI - Efficacy of the Bispecific Anti-BAFF/IL-21 Antibody CZ105 Bis2 in Models of Systemic Lupus Erythematosus. AU - Feng X AU - Long D AU - Yin H AU - Li L AU - Wang Z AU - Zhao J AU - Fan X AU - Wu W AU - Wu H AU - Lu Q PY - 2026 JO - Arthritis & rheumatology (Hoboken, N.J.) DO - 10.1002/art.70310 UR - https://doi.org/10.1002/art.70310 ER -
APA
X, F., D, L., H, Y., L, L., Z, W., J, Z., X, F., W, W., H, W., & Q, L. (2026). Efficacy of the Bispecific Anti-BAFF/IL-21 Antibody CZ105 Bis2 in Models of Systemic Lupus Erythematosus.. Arthritis & rheumatology (Hoboken, N.J.). https://doi.org/10.1002/art.70310
Source records
- pubmed · retrieved 2026-09-26T11:13:37.657Z